The glomerular mesangium. I. Kinetic studies of macromolecular uptake in normal and nephrotic rats.

PubWeight™: 2.26‹?› | Rank: Top 2%

🔗 View Article (PMC 292238)

Published in J Clin Invest on May 01, 1972

Authors

S M Mauer, A J Fish, E B Blau, A F Michael

Articles citing this

The permeability of glomerular capillaries to graded dextrans. Identification of the basement membrane as the primary filtration barrier. J Cell Biol (1974) 2.53

Role of marrow-derived monocytes and mesangial cells in removal of immune complexes from renal glomeruli. J Exp Med (1979) 2.27

Association and dissociation of aggregated IgG from rat peritoneal macrophages. J Exp Med (1977) 1.61

Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome. J Clin Invest (1983) 1.60

Application of the solid phase C1q and Raji cell radioimmune assays for the detection of circulating immune complexes in glomerulonephritis. J Clin Invest (1978) 1.50

Mechanisms of the puromycin-induced defects in the transglomerular passage of water and macromolecules. J Clin Invest (1977) 1.46

The glomerular mesangium. 3. Acute immune mesangial injury: a new model of glomerulonephritis. J Exp Med (1973) 1.40

The influence of phagocyte function on glomerular localization of aggregated IgM in rats. Clin Exp Immunol (1978) 1.38

Enhanced degradation of soluble immunoglobulin aggregates by macrophages in the presence of complement. Immunology (1979) 1.35

Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis. J Clin Invest (1988) 1.17

Clearance of soluble aggregates of human immunoglobulin G in healthy volunteers and chimpanzees. Clin Exp Immunol (1987) 1.12

Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging. Mol Cell Biol (2002) 1.09

Human glomerular cells in culture. Three subcultured cell types bearing glomerular antigens. Am J Pathol (1978) 1.06

The glomerular mesangium. II. Studies of macromolecular uptake in nephrotoxic nephritis in rats. J Clin Invest (1974) 1.02

Renal transplantation in diabetes mellitus in rats. J Exp Med (1974) 0.99

Evaluation of aggregated IgG in mice as an Fc receptor specific probe of the hepatic mononuclear phagocyte system. Clin Exp Immunol (1982) 0.98

Immunopathology of the end-stage kidney. Immunoglobulin and complement component deposition in nonimmune disease. Am J Pathol (1976) 0.98

Basal lamina heterogeneity in the glomerular capillary tufts of human kidneys. J Exp Med (1979) 0.95

Dimers and multimers of monoclonal IgG1 exhibit higher in vitro binding affinities to Fcgamma receptors. MAbs (2009) 0.93

Cadmium and the reticuloendothelial system (RES). A specific defect in blood clearance of soluble aggregates of IgG by the liver in mice given cadmium. Immunology (1980) 0.91

Non-specificity of circulating immune complexes in patients with acute and chronic liver disease. Clin Exp Immunol (1980) 0.91

The mesangium in anti-Thy-1 nephritis. Influx of macrophages, mesangial cell hypercellularity, and macromolecular accumulation. Am J Pathol (1990) 0.89

A mechanism of enhancement of immune complex deposition following in situ immune complex formation in the mouse glomerulus. Immunology (1981) 0.88

Nephrotic syndrome--no evidence for a role for IgE. Clin Exp Immunol (1973) 0.87

Quantitation of the intrarenal uptake of immunoglobulin aggregates by macrophages in diffuse proliferative glomerulonephritis. Clin Exp Immunol (1986) 0.86

Pathogenic role of polyclonal and polymeric IgA in a murine model of mesangial proliferative glomerulonephritis with IgA deposition. Clin Exp Immunol (1991) 0.84

Endothelin-1 release from cultured endothelial cells induced by sera from patients with systemic lupus erythematosus. Ann Rheum Dis (1995) 0.81

The mesangium in glomerular disease. Proc R Soc Med (1975) 0.81

Elimination of soluble 123I-labelled aggregates of human immunoglobulin G in humans; the effect of splenectomy. Clin Exp Immunol (1989) 0.81

Uptake of aggregated immunoglobulin by the mouse kidney. II. Effect of hydrocortisone. Br J Exp Pathol (1980) 0.81

Intravenous immunoglobulin in the management of lupus nephritis. Autoimmune Dis (2012) 0.80

Uptake of aggregated immunoglobulin by the mouse kidney. I. Effect of endotoxin. Br J Exp Pathol (1980) 0.80

The effect of charge on the renal distribution of ferritin. Am J Pathol (1983) 0.79

Effect of antibody avidity on the induction of renal injury in anti-glomerular basement membrane nephritis. Br J Exp Pathol (1978) 0.79

Quantitating glomerular endothelial fenestration: an unbiased stereological approach. Am J Nephrol (2011) 0.78

Differential expression of functional Fc-receptors and additional immune complex receptors on mouse kidney cells. Mol Immunol (2013) 0.77

Mesangial function in ureteral obstruction in the rat. Blockade of the efferent limb. J Clin Invest (1979) 0.76

The effect of protein deficiency on the development of chronic antigen-antibody complex disease in mice. Clin Exp Immunol (1981) 0.75

Solubilization of immune complex deposits by native 7S IgG molecules in lupus glomerulonephritis--a possible antigen excess effect on rheumatoid factor-IgG complexes. Clin Exp Immunol (1984) 0.75

The detection of circulating immune complexes in renal transplant patients. Clin Exp Immunol (1980) 0.75

Articles cited by this

Glomerular permeability. I. Ferritin transfer across the normal glomerular capillary wall. J Exp Med (1961) 7.03

Glomerular permeability. II. Ferritin transfer across the glomerular capillary wall in nephrotic rats. J Exp Med (1961) 4.85

Acute poststreptococcal glomerulonephritis: immune deposit disease. J Clin Invest (1966) 4.64

EXPERIMENTAL GLOMERULONEPHRITIS. IV. PARTICIPATION OF COMPLEMENT IN NEPHROTOXIC NEPHRITIS. J Exp Med (1964) 4.36

Biologic activities of aggregated gamma-globulin. 8. Aggregated immunoglobulins of different classes. J Immunol (1967) 3.37

Studies of aggregated gamma-globulin. I. Sedimentation, electrophoretic and anticomplementary properties. J Immunol (1960) 3.36

Localization of colloidal substances in vascular endothelium: a mechanism of tissue damage. I. Factors causing the pathologic deposition of colloidal carbon. Am J Pathol (1959) 3.28

Aminonucleoside nephrosis. I. Electron microscopic study of the renal lesion in rats. J Exp Med (1959) 2.20

Glomerular localization and transport of aggregated proteins in mice. Lab Invest (1967) 1.94

Studies of aggregated gamma-globulin. II. Effect in vivo. J Immunol (1960) 1.85

Relations of the centrolobular region of the glomerulus to the juxtaglomerular apparatus. J Ultrastruct Res (1962) 1.81

Anaphylactoid purpura. II. Immunofluorescent and electron microscopic studies of the glomerular lesions. Lab Invest (1968) 1.63

DEPOSITION OF AUTOLOGOUS GAMMA GLOBULIN IN KIDNEYS OF RATS WITH NEPHROTIC RENAL DISEASE OF VARIOUS ETIOLOGIES. J Lab Clin Med (1965) 1.54

TRANSPORT OF GLOBIN BY THE RENAL GLOMERULUS. J Exp Med (1964) 1.49

A unique influence of cortisone on the transit of specific macromolecules across vascular walls in immune complex disease. Johns Hopkins Med J (1968) 1.40

Rat glomerular basement membrane composition and metabolism in aminonucleoside nephrosis. J Lab Clin Med (1971) 1.23

The production of chronic renal disease in rats by a single intravenous injection of aminonucleoside of puromycin and the effect of low dosage continuous hydrocortisone. Br J Exp Pathol (1963) 1.16

The glomerular mesangium. A quantitative analysis. Lab Invest (1968) 1.10

Studies of the human fetal kidney. II. Permeability characteristics of the developing glomerulus. J Ultrastruct Res (1963) 0.97

The ultrastructure of the juxtaglomerular apparatus as disclosed by three-dimensional reconstructions from serial sections. The anatomical relationship between the tubular and vascular components. J Ultrastruct Res (1970) 0.95

Electron Microscopic Studies on the Development of the Glomerular Lesions in Aminonucleoside Nephrosis. Am J Pathol (1961) 0.87

LUPUS GLOMERULONEPHRITIS. THE EFFECT OF LARGE DOSES OF CORTICOSTEROIDS ON RENAL FUNCTION AND RENAL LESIONS IN TWO CHILDREN. Am J Dis Child (1965) 0.83

Articles by these authors

Structural-functional relationships in diabetic nephropathy. J Clin Invest (1984) 4.78

Acute poststreptococcal glomerulonephritis: immune deposit disease. J Clin Invest (1966) 4.64

Glomerular polyanion. Alteration in aminonucleoside nephrosis. Lab Invest (1970) 3.82

Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell (1991) 3.19

Glomerular deposition of properdin in acute and chronic glomerulonephritis with hypocomplementemia. J Clin Invest (1971) 3.06

Pancreas and kidney/pancreas transplants: experimental medicine or real improvement? Lancet (1994) 2.73

Retardation of fading and enhancement of intensity of immunofluorescence by p-phenylenediamine. J Histochem Cytochem (1983) 2.44

Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease. J Clin Invest (1983) 2.39

Localization of immunological complexes fixing beta1C (C3) in germinal centers of lymph nodes. J Exp Med (1969) 2.36

Properdin anc C3 proactivator: alternate pathway components in human glomerulonephritis. J Clin Invest (1973) 2.33

Immune cell populations in cutaneous delayed-type hypersensitivity. J Exp Med (1983) 2.33

Human glomerular basement membrane. Preparation and composition. Biochemistry (1970) 2.26

Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. N Engl J Med (1989) 2.21

Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest (1980) 2.11

Activation of complement by cell surface components of Staphylococcus aureus. Infect Immun (1978) 2.03

The nephrotic syndrome of childhood: immunologic, clinical, and pathologic correlations. J Clin Invest (1966) 1.96

Chronic glomerulonephritis associated with low serum complement activity (chronic hypocomplementemic glomerulonephritis). Medicine (Baltimore) (1970) 1.94

Glomerular localization and transport of aggregated proteins in mice. Lab Invest (1967) 1.94

Familial granulomatous arthritis, iritis, and rash. J Pediatr (1985) 1.90

Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89

The glomerular mesangium. Kidney Int (1980) 1.83

Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83

Congenital nephrotic syndrome: evolution of medical management and results of renal transplantation. J Pediatr (1984) 1.82

Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest (1985) 1.80

Hereditary C2 deficiency: Genetic studies and association with the HL-A system. J Exp Med (1975) 1.75

Studies of the rate of regression of the glomerular lesions in diabetic rats treated with pancreatic islet transplantation. Diabetes (1975) 1.74

Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet (1972) 1.71

Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys. Lancet (1993) 1.70

Autoimmune phenomena and renal disease in mice. Role of thymectomy, aging, and involution of immunologic capacity. Lab Invest (1970) 1.69

Glomerular sialic acid and proteinuria in human renal disease. Lab Invest (1973) 1.67

Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65

Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N Engl J Med (1988) 1.65

Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes (1989) 1.64

Polyantigenic expansion of basement membrane constituents in diabetic nephropathy. Diabetes (1983) 1.64

Kindey transplantation: experiences at the University of Minnesota Hospitals. Surgery (1967) 1.62

Interstitial mononuclear cell populations in renal graft rejection. Identification by monoclonal antibodies in tissue sections. J Exp Med (1982) 1.59

Effect of glycemic control on early diabetic renal lesions. A 5-year randomized controlled clinical trial of insulin-dependent diabetic kidney transplant recipients. JAMA (1994) 1.57

Dichotomy between opsonization and serum complement activation by encapsulated staphylococci. Infect Immun (1978) 1.56

The effects of Goldblatt hypertension on development of the glomerular lesions of diabetes mellitus in the rat. Diabetes (1978) 1.52

Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes (1992) 1.51

Stages of renal ontogenesis identified by monoclonal antibodies reactive with lymphohemopoietic differentiation antigens. J Exp Med (1983) 1.48

The kidney in diabetes. Am J Med (1981) 1.47

Inherited deficiency of the second component of complement (C2) with membranoproliferative glomerulonephritis. Am J Med (1977) 1.46

Dietary restrictions early and late: effects on the nephropathy of the NZB X NZW mouse. Lab Invest (1978) 1.45

Immunofluorescent localization of antihemophilic factor antigen and fibrinogen in human renal diseases. J Clin Invest (1974) 1.44

Immunohistopathology of diabetic glomerulosclerosis. Diabetes (1972) 1.44

Epidemic acute glomerulonephritis associated with type 49 streptococcal pyoderma. II. Correlative study of light, immunofluorescent and electron microscopic findings. Am J Med (1970) 1.42

The glomerular mesangium. 3. Acute immune mesangial injury: a new model of glomerulonephritis. J Exp Med (1973) 1.40

Uremic pericardial effusion. Treatment by catheter drainage and local nonabsorbable steroid administration. Nephron (1976) 1.39

Acute serum sickness nephritis in the rabbit. An immune deposit disease. Am J Pathol (1966) 1.38

The secretory immune system and renal disease. Clin Exp Immunol (1975) 1.36

Unilateral renal disease in the rat. I. Clinical, morphologic, and glomerular mesangial functional features of the experimental model produced by renal perfusion with aminonucleoside. J Lab Clin Med (1975) 1.36

The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes. N Engl J Med (1989) 1.35

Estimation of glomerular volume: a comparison of four methods. Kidney Int (1992) 1.35

A solid phase fluorescent immunoassay for the measurement of human urinary albumin. Kidney Int (1984) 1.34

Nephritogenic antigen determinants in epidermal and renal basement membranes of kindreds with Alport-type familial nephritis. J Clin Invest (1986) 1.33

Unilateral and bilateral renal agenesis in monoamniotic twins. J Pediatr (1974) 1.33

Human corneal basement membrane heterogeneity: topographical differences in the expression of type IV collagen and laminin isoforms. Lab Invest (1995) 1.33

Basement membrane collagen in the kidney: regional localization of novel chains related to collagen IV. Kidney Int (1989) 1.32

Human glomerular smooth muscle (mesangial) cells in culture. Lab Invest (1976) 1.31

Monoclonal antibodies to human renal basement membranes: heterogenic and ontogenic changes. Kidney Int (1983) 1.31

Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosis. Lab Invest (1977) 1.28

Diabetic glomerulopathy following unilateral nephrectomy in the rat. Diabetes (1978) 1.28

Studies of the alternate pathway in chelated serum. J Lab Clin Med (1975) 1.26

Detection of hidden nephritogenic antigen determinants in human renal and nonrenal basement membranes. Am J Pathol (1985) 1.26

Renal transplantation in children ages 1 to 5 years. Pediatrics (1978) 1.25

Spontaneous immunoglobulin and complement deposition in glomeruli of diabetic rats. Lab Invest (1972) 1.24

Renal interstitial expansion in insulin-dependent diabetes mellitus. Kidney Int (1993) 1.23

Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats. J Lab Clin Med (1980) 1.23

Rat glomerular basement membrane composition and metabolism in aminonucleoside nephrosis. J Lab Clin Med (1971) 1.23

Avascular necrosis of bone in systemic lupus erythematosus. J Pediatr (1974) 1.23

The complement system in chronic glomerulonephritis: three newly associated aberrations. J Pediatr (1971) 1.21

Studies of diabetic nephropathy in animals and man. Diabetes (1976) 1.21

Development of diabetic vascular lesions in normal kidneys transplanted into patients with diabetes mellitus. N Engl J Med (1976) 1.21

Alport syndrome. Kidney Int (1996) 1.20

A 10-year experience with 290 pancreas transplants at a single institution. Ann Surg (1989) 1.19

Rat glomerular glycoprotein composition and metabolism in aminonucleoside nephrosis. Proc Soc Exp Biol Med (1972) 1.19

Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion. Diabetes (1992) 1.19

Quantitative glomerular morphology of the normal human kidney. Lab Invest (1983) 1.18

Exchange transfusion in the treatment of hepatic coma. J Pediatr (1969) 1.18

Immunosuppressive therapy of chronic renal disease. N Engl J Med (1967) 1.18